Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

Last week, a Florida District Court judge dismissed Novo Nordisk’s lawsuit against Brooksville Pharmacy, one of the four APC members the drugmaker sued back in June over semaglutide compounding in shortage. Though the order was issued, the opinion has not yet been released.

According to STAT News:

U.S. District Court Judge William Jung left the door open for Novo Nordisk to file an amended lawsuit. This suggests the case may continue if drug maker takes such a step. A Novo Nordisk spokeswoman told us the company plans to file an amended lawsuit explaining why it believes the pharmacy violated Florida state law.

APC intends to file amicus briefs in the remaining three Novo cases. Also, the APC Executive Committee this week voted to file amicii in similar lawsuits filed by Eli Lilly against APC members over tirzepatide compounding in shortage.

For now, congrats to Terry Myers and his crew at Brooksville Pharmacy and to his attorneys at Frier Levitt in this initial win. If you want to support APC’s Legal Action Fund, which fuels our ability to engage in cases like these, here’s where to do that: A4PC.org/legalactionfund.